- Home
- ECOR vs DXR Comparison
ECOR vs DXR Comparison
Compare ECOR & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- DXR
- Stock Information
- Founded
- ECOR 2005
- DXR 1970
- Country
- ECOR United States
- DXR United States
- Employees
- ECOR N/A
- DXR N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DXR Medical/Dental Instruments
- Sector
- ECOR Health Care
- DXR Health Care
- Exchange
- ECOR Nasdaq
- DXR Nasdaq
- Market Cap
- ECOR 39.7M
- DXR 46.1M
- IPO Year
- ECOR 2018
- DXR N/A
- Fundamental
- Price
- ECOR $7.75
- DXR $10.14
- Analyst Decision
- ECOR Strong Buy
- DXR Strong Buy
- Analyst Count
- ECOR 2
- DXR 1
- Target Price
- ECOR $25.50
- DXR $25.00
- AVG Volume (30 Days)
- ECOR 118.8K
- DXR 3.2K
- Earning Date
- ECOR 08-06-2025
- DXR 01-01-0001
- Dividend Yield
- ECOR N/A
- DXR N/A
- EPS Growth
- ECOR N/A
- DXR 86.16
- EPS
- ECOR N/A
- DXR 0.11
- Revenue
- ECOR $26,458,000.00
- DXR $119,714.00
- Revenue This Year
- ECOR $23.21
- DXR N/A
- Revenue Next Year
- ECOR $44.10
- DXR N/A
- P/E Ratio
- ECOR N/A
- DXR $92.00
- Revenue Growth
- ECOR 41.54
- DXR N/A
- 52 Week Low
- ECOR $4.47
- DXR $6.55
- 52 Week High
- ECOR $19.49
- DXR $10.23
- Technical
- Relative Strength Index (RSI)
- ECOR 64.43
- DXR 65.31
- Support Level
- ECOR $6.57
- DXR $9.05
- Resistance Level
- ECOR $7.80
- DXR $9.90
- Average True Range (ATR)
- ECOR 0.74
- DXR 0.29
- MACD
- ECOR 0.03
- DXR 0.02
- Stochastic Oscillator
- ECOR 63.97
- DXR 100.00
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.